Go to content
OctoPlus N.V.

OctoPlus N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 23 jun 2009 - 07:29
Statutaire naam OctoPlus N.V.
Titel OctoPlus opens new GMP manufacturing facility
Bericht OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO) announces today that it has started pharmaceutical production in its new manufacturing facility in Leiden. The facility has received a license from the Dutch authorities to manufacture pharmaceutical products according to international GMP (Good Manufacturing Practice) guidelines and the first production has taken place successfully.